友邦(01299.HK)與印度數碼保健平台Practo建立策略夥伴關係
友邦保險(01299.HK)公布,與印度數碼保健平台Practo建立長期策略夥伴關係,友邦保險在印度的合資公司Tata AIA Life將透過是次策略夥伴關係與Practo展開合作,Tata AIA Life客戶將可優先接觸Practo的數碼保健平台服務,有關平台提供的服務包括網上醫生咨詢服務、搜尋門診診所並預約服務、訂購藥品及預約診斷測試。
公布指,Practo網絡覆蓋印度的7萬間醫院和診所,及逾10萬名名醫生。Tata AIA Life亦將成為Practo數碼保健平台1.75億用戶的獨家人壽保險方案及相關健康主張的供應商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.